IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$8.3M
3
+$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.39M

Top Sells

1
+$11.5M
2
+$7.89M
3
+$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$6.2M

Sector Composition

1 Healthcare 97.45%
2 Consumer Staples 0.57%
3 Technology 0.57%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
176
– –
0
177
– –
0
178
– –
-6,496
179
– –
-134,575
180
– –
-36,240
181
– –
0
182
– –
0
183
– –
0
184
– –
-211,670
185
– –
-9,953
186
– –
-53,370
187
– –
0
188
– –
0
189
– –
0
190
– –
-670,771
191
– –
0
192
– –
-100,000
193
– –
0
194
– –
0
195
– –
0
196
– –
0
197
– –
-32,666
198
– –
-26,632
4 5 6 7
8